Marshall's Treatments
The information given below & the tabulated information in the next section was compiled by the following authors & others (named in each section).
|
|
|
The data was comparable with that presented at the American Gastrointestinal Association conference held in Washington D.C. in May 1997. Most Data are still valid as at July 2006.
Please Note that 20mg omeprazole and 30 mg lansoprazole are equivalent in most treatments.
Conventional First-Line Triple Therapies-(Twice-Daily PPI-Based Triple Therapies)
Cure rate 90%:with 2 weeks treatment in the U.S.; 1 week Treatment outside U.S.
- Omeprazole 20 mg bid or Lansoprazole 30 mg bid
- Clarithromycin 500 mg bid
- Amoxicillin 1 g bid
- or Metronidazole 500 mg bid if Amoxicillin intolerant
Traditional Bismuth-Based Triple Therapy
Cure rate 80% with 2 weeks Treatment (USA) ;
Cure rate outside U.S.A.: 90% with 1-2 weeks Treatment
-
Bismuth subsalicylate (Pepto-Bismol) 2 ( How many mg???) tablets qid in U.S.
- OR
-
De-Nol [Colloidal bismuth subcitrate ]* 120mg qid outside U.S.)
- Tetracycline 500 mg qid
- Metronidazole 400 mg qid
- Proton Pump Inhibitor (20mg Omeprazole bid or 30 mg lansoprazole. bid
*De-Nol (Colloidal Bismuth Subcitrate) is Available in Australia Under the TGA's Special Access Scheme (SAS) Contact Tri-Med Distributors P/L; Email sales@trimed.com.au; Ph. +61 8 9388 1444
Furazolidone & Bismuth Based (Second Line) Quadruple Therapies
Cure Rate >92% Duration of Treatment 14 days
- Furazolidone 200mg bid
- Colloidal Bismuth Subcitrate (De-Nol) 120mg qid
- Amoxicillin 1000mg bid
- 20mg Omeprazole bid OR 30 mg lansoprazole. bid
Third-Line Quadruple "Salvage Therapy" ( Marshall Therapy)
- Ciprofloxacin 500mg bid
- Rifabutin* 150mg bid
- Omeprazole 40mg tds (six times the normal dose)
- Amoxycillin 1000mg tds
* Rifabutin is only available through a Hospital Pharmacy
Other Triple Therapies - Twice-Daily RBC-Based Triple Therapy
Cure rate 90% with 2 weeks treatment.
- Ranitidine bismuth citrate (RBC)* 400 mg bid
- Clarithromycin 500 mg bid
- Amoxicillin 1 g bid (or metronidazole 500 mg bid if Amoxicillin intolerant)
*RBC has been de-listed in Australlia; However, De-Nol can be substituted for RBC. De-Nol is Available in Australia Under the TGA's Special Access Scheme (SAS) Contact Tri-Med Distributors P/L; Email sales@trimed.com.au; Ph. +61 8 9388 1444
Other US-FDA-Approved Dual Therapies
Cure rate 70% at 2 weeks
- Omeprazole 40 mg qid
- Clarithromycin 500 mg tid
Cure rate 80% at 2 weeks
- Ranitidine bismuth citrate 400 mg bid
- Clarithromycin 500 mg tid
Common Trade Names for drugs used
Trade name |
Active Ingredient (Generic Name) |
Manufacturer/Distributor
|
|
Biaxin, Klacid (Australia)
|
clarithromycin |
Abbott |
|
Flagyl (Australia)
|
metronidazole |
Generic |
|
Tritec (USA)
|
ranitidine bismuth citrate |
Glaxo-Wellcome |
|
Prilosec (USA) , Losec (Australia)
|
omeprazole |
Astra-Zeneka / Merck |
|
Prevacid USA); Zoton (Australia)
|
lansoprazole |
Lederle |
|
De-Nol (Australia)
Peptobismol (USA)
|
Colloidal Bismuth Subcitrate
Bismuth Subslicylate |
Tri-Med Australia |
|
Furasian
|
Furazolidone |
Tri-Med Australia |


